This memorandum supplements existing requirements with respect to coronavirus disease 2019 (COVID-19), and replaces Force Health Protection Supplement #4. It provides pre- and post-travel guidance for purposes of force health protection (FHP) of Service members, DoD family members, DoD civilian employees, and DoD contractor personnel. Nothing in this guidance waives the requirement to adhere to Centers for Disease Control and Prevention (CDC) guidance to the greatest extent practicable.
This memorandum outlines the Department of Defense surveillance strategy for the coronavirus disease 2019 (COVID-19) pandemic response, including health surveillance activities, screening, asymptomatic testing, and sentinel surveillance testing. It complements clinical and diagnostic testing guidance set forth in ”Force Health Protection Guidance (Supplement 10)-Department of Defense Guidance for Coronavirus Disease 2019 Laboratory Diagnostic Testing Services," dated June 11, 2020.
This memorandum updates previous DoD coronavirus disease 2019 (COVID-19) laboratory testing guidance and rescinds ”Force health Protection (Supplement 6) - Department of Defense Guidance for Coronavirus Disease 2019 Laboratory Diagnostic Testing Services," dated April 7, 2020. This force health protection (FHP) supplement provides guidance on clinical and diagnostic COVID-19 testing for eligible persons with a DoD connection suspected of having contracted COVID-19, and applies Centers for Disease Control and Prevention (CDC) testing guidance to the DoD context.
This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic.
This memorandum supplements “Secretary of Defense Memorandum, ‘Guidance for Commanders on the Implementation of the Risk Based Responses to the COVID-19 Pandemic,’ April 1, 2020” and provides guidance for commanders to consider when making decisions to change health protection condition (HPCON) levels as COVID-19 pandemic conditions on and adjacent to our installations begin to improve.
This memorandum provides guidance on how each Military Medical Treatment Facility (MTF) and Dental Treatment Facility (DTF) my resume elective medical and dental procedures.
This document further supplements previous instructions and provides additional guidance to All DoD Components to immediately implement appropriate procedures to protect all personnel from disease transmission in DoD workplaces.
This document rescinds Force Health Protection Guidance Supplement #3 and provides updated guidance on use of cloth face coverings, medical PPE, and reinforces Non-Pharmaceutical interventions for COVID-19 response.
This document provides DoD laboratory testing guidance to protect at-risk populations, maximize critical testing capability, and enable optimal public health decision-making. Diagnostic testing will be used in support of patient care.
This document provides DoD medical personnel with best practices for the evaluation, treatment, and management of COVID-19, Patient movement guidance to protect the transportation crew and other patients, and guidance on post-transport management of contaminated vehicles.
DoD has experienced a significant increase in the number and scale in request of airlifts of patients, passengers, and cargo from across the Federal Government and Non-U.S. Government Organizations. This memo provides guidance on the delegation of authorities in order to make timely action on patient movement and transportation requests approval.
This memorandum captures previously issued verbal guidance, and provides the Secretary of Defense intent for military commanders as they make and implement critical local decisions in the coming weeks and months. The department anticipates remaining at HPCON “C” as a global posture for the foreseeable future. Memo provides guidance to local commanders to exercise mission command by making rapid decisions above HPCON "C" if required to protect the force.
The Secretary of Defense anticipates an increase in requests for assistance from interagency and civilian sources, as well as, increasing challenges to maintain the readiness of our force and the health of our military families. He directs Military Departments to provide a complete list of all active duty and civilian medical personnel, a report of each installation's health protection condition status, and identify if any installation is having difficulty meeting the requirements of their Pandemic Influenza contingency plan.
Directs all Military Medical Treatment Facilities (MTFs) and Dental Treatment Facilities (DTFs) to postpone all elective surgeries, invasive procedures, and dental procedures as of March 31, 2020 for 60 days in order align with actions being taken across the nation to conserve vital healthcare resources for expected surges in the COVID-19 public health emergency.
FACT SHEET AND Q&A: ELECTIVE SURGERY AND PROCEDURES
This document provides pre and post-travel health care guidelines to all DoD travelers. A chart indicating health care measures based on the CDC THN level helps leaders meet the guidelines laid forth to ensure the readiness of the force.
Addressed to DoD Components and the Military Departments, this document prioritizes use of medical PPE and provides guidance to reinforce interventions for COVID-19 response.
Serves as a supplement to DoDI 6200.3 "Public Health Emergency Management with in DoD" that provides Military Installation Commanders a risk- based framework to help guide their response to COVID-19.
DoD Components will identify Service Members returning from mainland china after 02 February 2020 and place in a 14-day restriction of movement. Provides guidance to DoD civilians, contractors, and family members returning from China to follow CDC guidelines.
Initial Guidance to DoD personnel on the COVID-19 outbreak. Document lays out the situation and aligns DoD healthcare actions with CDC published guidance.